Primecap Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.59M Sell
35,700
-200
-0.6% -$23.4K ﹤0.01% 288
2026
Q1
$4.32M Sell
35,900
-2,100
-6% -$242K ﹤0.01% 283
2025
Q4
$4M Sell
38,000
-8,000
-17% -$751K ﹤0.01% 286
2025
Q3
$3.86M Sell
46,000
-5,900
-11% -$486K ﹤0.01% 287
2025
Q2
$4.11M Sell
51,900
-5,600
-10% -$445K ﹤0.01% 290
2025
Q1
$5.16M Sell
57,500
-2,900
-5% -$271K ﹤0.01% 280
2024
Q4
$6.01M Sell
60,400
-6,400
-10% -$660K ﹤0.01% 269
2024
Q3
$7.59M Sell
66,800
-6,000
-8% -$713K 0.01% 274
2024
Q2
$9.01M Sell
72,800
-3,200
-4% -$412K 0.01% 262
2024
Q1
$10M Sell
76,000
-8,500
-10% -$1.05M 0.01% 261
2023
Q4
$9.21M Sell
84,500
-8,500
-9% -$882K 0.01% 265
2023
Q3
$9.57M Sell
93,000
-3,100
-3% -$334K 0.01% 258
2023
Q2
$11.1M Sell
96,100
-4,800
-5% -$545K 0.01% 253
2023
Q1
$10.7M Sell
100,900
-6,500
-6% -$702K 0.01% 253
2022
Q4
$11.9M Sell
107,400
-9,100
-8% -$930K 0.01% 241
2022
Q3
$10M Sell
116,500
-18,400
-14% -$1.64M 0.01% 251
2022
Q2
$12.3M Sell
134,900
-6,700
-5% -$594K 0.01% 240
2022
Q1
$11.6M Sell
141,600
-102,100
-42% -$8.05M 0.01% 255
2021
Q4
$18.7M Sell
243,700
-268,700
-52% -$21.4M 0.01% 245
2021
Q3
$38.5M Sell
512,400
-8,300
-2% -$631K 0.03% 207
2021
Q2
$40.5M Sell
520,700
-706,927
-58% -$52.6M 0.03% 206
2021
Q1
$90.3M Sell
1,227,627
-1,373,299
-53% -$101M 0.06% 162
2020
Q4
$203M Sell
2,600,926
-166,213
-6% -$12.7M 0.15% 112
2020
Q3
$219M Sell
2,767,139
-180,361
-6% -$14.1M 0.18% 102
2020
Q2
$217M Sell
2,947,500
-304,549
-9% -$22.9M 0.19% 102
2020
Q1
$239M Sell
3,252,049
-315,448
-9% -$24.8M 0.23% 85
2019
Q4
$310M Hold
3,567,497
0.22% 94
2019
Q3
$287M Sell
3,567,497
-7,441
-0.2% -$596K 0.23% 95
2019
Q2
$286M Hold
3,574,938
0.21% 106
2019
Q1
$284M Hold
3,574,938
0.21% 104
2018
Q4
$261M Hold
3,574,938
0.21% 99
2018
Q3
$242M Hold
3,574,938
0.16% 114
2018
Q2
$207M Hold
3,574,938
0.15% 115
2018
Q1
$186M Sell
3,574,938
-2,267,733
-39% -$122M 0.14% 116
2017
Q4
$314M Buy
5,842,671
+155,909
+3% +$8.64M 0.24% 90
2017
Q3
$347M Buy
5,686,762
+329,910
+6% +$20M 0.29% 81
2017
Q2
$328M Buy
5,356,852
+247,538
+5% +$15.1M 0.28% 81
2017
Q1
$310M Buy
5,109,314
+2,008,177
+65% +$122M 0.28% 79
2016
Q4
$174M Sell
3,101,137
-5,449
-0.2% -$319K 0.17% 108
2016
Q3
$185M Sell
3,106,586
-3,564
-0.1% -$208K 0.18% 101
2016
Q2
$171M Sell
3,110,150
-26,304
-0.8% -$1.4M 0.18% 103
2016
Q1
$158M Buy
3,136,454
+212,534
+7% +$10.4M 0.16% 105
2015
Q4
$147M Buy
2,923,920
+151,960
+5% +$7.66M 0.15% 110
2015
Q3
$131M Buy
2,771,960
+631,944
+30% +$33.6M 0.15% 116
2015
Q2
$116M Buy
2,140,016
+688,536
+47% +$38.6M 0.11% 130
2015
Q1
$79.6M Buy
1,451,480
+717,880
+98% +$40.6M 0.08% 149
2014
Q4
$39.8M Buy
+733,600
New +$40.9M 0.04% 180

Other funds holding MRK

Primecap Management's MRK Position: Q2 2026 in Review

Primecap Management reduced its Merck (MRK) stake by 0.56% in Q2 2026, selling an estimated $23.4K and leaving 35,700 shares worth $4.59M. The position accounts for ﹤0.01% of the portfolio, ranked #288.

Primecap Management first reported a position in MRK in Q4 2014 and has held it in 47 quarters since. The position peaked at $347M in Q3 2017. 3,820 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Primecap Management held 35,700 shares of Merck worth $4.59M as of Q2 2026.
  • Primecap Management sold 200 Merck shares in Q2 2026, an estimated $23.4K.
  • Merck made up ﹤0.01% of Primecap Management's portfolio in Q2 2026, its #288 holding.
  • Primecap Management first reported a position in Merck in Q4 2014 and has held it in 47 quarters since.
  • Primecap Management's Merck position peaked at $347M in Q3 2017.
  • 3,820 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Primecap Management's 13F filing for Q2 2026, filed 14 Aug 2026.